Italy halts AstraZeneca vaccine for under-60s after teenager dies Reuters via biedexmarkets.com


© Reuters. FILE PHOTO: A nurse prepares a dose of AstraZeneca coronavirus disease (COVID-19) vaccine in Fasano Italy, April 13, 2021. REUTERS/Alessandro Garofalo/File Photo

ROME (Reuters) – The Italian government said on Friday it was restricting the use of the AstraZeneca (NASDAQ:) COVID-19 vaccine to people over the age of 60, after a teenager who had taken the shot died from a blood clot.

Camilla Canepa died on Thursday aged 18 after being given the vaccine on May 25, triggering a storm of controversy in Italy over the Anglo-Swedish brand being given to adults of all ages despite previously-raised medical concerns.

“AstraZeneca will only be used for people over 60,” the country’s special COVID commissioner Francesco Figliuolo told reporters at a news conference.

Get Stock Market Insights, Technical Analysis, Live Market Data, ratings, insider trades
Logo
Compare items
  • Total (0)
Compare
Shopping cart